Correlation Between HCA Healthcare and Cizzle Biotechnology

Can any of the company-specific risk be diversified away by investing in both HCA Healthcare and Cizzle Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCA Healthcare and Cizzle Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCA Healthcare and Cizzle Biotechnology Holdings, you can compare the effects of market volatilities on HCA Healthcare and Cizzle Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCA Healthcare with a short position of Cizzle Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCA Healthcare and Cizzle Biotechnology.

Diversification Opportunities for HCA Healthcare and Cizzle Biotechnology

0.8

Correlation Coefficient

HCA Healthcare  Cizzle Biotechnology

Very poor diversification

The 3 months correlation between HCA and Cizzle is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding HCA Healthcare and Cizzle Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cizzle Biotechnology and HCA Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCA Healthcare are associated (or correlated) with Cizzle Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cizzle Biotechnology has no effect on the direction of HCA Healthcare i.e., HCA Healthcare and Cizzle Biotechnology go up and down completely randomly.

Pair Corralation between HCA Healthcare and Cizzle Biotechnology

Assuming the 90 days trading horizon HCA Healthcare is expected to under-perform the Cizzle Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, HCA Healthcare is 1.57 times less risky than Cizzle Biotechnology. The stock trades about -0.19 of its potential returns per unit of risk. The Cizzle Biotechnology Holdings is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  200.00  in Cizzle Biotechnology Holdings on October 8, 2024 and sell it today you would lose (40.00) from holding Cizzle Biotechnology Holdings or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.41%
Values	Daily Returns

HCA Healthcare  vs.  Cizzle Biotechnology Holdings

HCA Healthcare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HCA Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cizzle Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cizzle Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with HCA Healthcare and Cizzle Biotechnology

The main advantage of trading using opposite HCA Healthcare and Cizzle Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCA Healthcare position performs unexpectedly, Cizzle Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cizzle Biotechnology will offset losses from the drop in Cizzle Biotechnology's long position.

The idea behind HCA Healthcare and Cizzle Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.